» Articles » PMID: 35530592

Effects of Linker and Liposome Anchoring on Lactose-functionalized Glycomacromolecules As Multivalent Ligands for Binding Galectin-3

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 9
PMID 35530592
Authors
Affiliations
Soon will be listed here.
Abstract

In this work, we present a bottom-up approach for the synthesis of lactose-functionalized glycomacromolecules and glycofunctionalized liposomes and apply these compounds to investigate their effects of multivalent presentation on binding to galectin-3. Step-wise assembly of tailor-made building blocks on solid supports was used to synthesize a series of oligo(amidoamine) scaffolds that were further conjugated to lactose copper catalyzed 1,3-dipolar cycloaddition. Binding studies with galectin-3 revealed affinities in the micromolar range that increased with increasing carbohydrate valency, and decreased with increasing size and linker flexibility. To further explore their multivalency, selected glycomacromolecules were conjugated to lipids and used in liposomal formulations. Binding studies show a further increase in binding in nanomolar ranges in dependence of both ligand structure and liposomal presentation, demonstrating the power of combining the two approaches.

Citing Articles

Synthesis of a multivalent α-1,2-mannobiose ligand for targeting C-type lectins.

Langer J, Hartmann L, Snyder N RSC Adv. 2024; 14(51):37950-37959.

PMID: 39610811 PMC: 11603336. DOI: 10.1039/d4ra06526c.


Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design.

Clemente B, Denis M, Silveira C, Schiavetti F, Brazzoli M, Stranges D Front Immunol. 2023; 14:1294929.

PMID: 38090568 PMC: 10711611. DOI: 10.3389/fimmu.2023.1294929.


Molecular Recognition of Glycan-Bearing Glycomacromolecules Presented at Membrane Surfaces by Lectins: An NMR View.

Lete M, Hoffmann M, Schomann N, Martinez-Castillo A, Peccati F, Konietzny P ACS Omega. 2023; 8(19):16883-16895.

PMID: 37214724 PMC: 10193412. DOI: 10.1021/acsomega.3c00634.


Synthesis, binding affinity, and inhibitory capacity of cyclodextrin-based multivalent glycan ligands for human galectin-3.

Ou C, Li C, Feng C, Tong X, Vasta G, Wang L Bioorg Med Chem. 2022; 72:116974.

PMID: 36108470 PMC: 10349921. DOI: 10.1016/j.bmc.2022.116974.


Synthesis and evaluation of porphyrin glycoconjugates varying in linker length: preliminary effects on the photodynamic inactivation of .

Dixon C, Nottingham A, Lozano A, Sizemore J, Russell L, Valiton C RSC Adv. 2021; 2021(12):7037-7042.

PMID: 34336191 PMC: 8320722. DOI: 10.1039/d0ra10793j.


References
1.
Boons G . Liposomes modified by carbohydrate ligands can target B cells for the treatment of B-cell lymphomas. Expert Rev Vaccines. 2010; 9(11):1251-6. PMC: 3016876. DOI: 10.1586/erv.10.121. View

2.
Nangia-Makker P, Conklin J, Hogan V, Raz A . Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol Med. 2002; 8(4):187-92. DOI: 10.1016/s1471-4914(02)02295-5. View

3.
Zhang S, Xiao Q, Sherman S, Muncan A, Ramos Vicente A, Wang Z . Glycodendrimersomes from Sequence-Defined Janus Glycodendrimers Reveal High Activity and Sensor Capacity for the Agglutination by Natural Variants of Human Lectins. J Am Chem Soc. 2015; 137(41):13334-44. DOI: 10.1021/jacs.5b08844. View

4.
Sundqvist M, Welin A, Elmwall J, Osla V, Nilsson U, Leffler H . Galectin-3 type-C self-association on neutrophil surfaces; The carbohydrate recognition domain regulates cell function. J Leukoc Biol. 2018; 103(2):341-353. DOI: 10.1002/JLB.3A0317-110R. View

5.
Chang C, Chen W, Gilson M . Ligand configurational entropy and protein binding. Proc Natl Acad Sci U S A. 2007; 104(5):1534-9. PMC: 1780070. DOI: 10.1073/pnas.0610494104. View